Browse using
OpenLink Faceted Browser
OpenLink Structured Data Editor
LodLive Browser
Formats
RDF:
N-Triples
N3
Turtle
JSON
XML
OData:
Atom
JSON
Microdata:
JSON
HTML
Embedded:
JSON
Turtle
Other:
CSV
JSON-LD
Faceted Browser
Sparql Endpoint
About:
http://dbpedia.org/class/yago/Antibody115027189
An Entity of Type:
Thing
,
from Named Graph:
http://dbpedia.org
,
within Data Space:
dbpedia.org
Property
Value
rdfs:
subClassOf
yago
:Protein114728724
owl:
equivalentClass
yago-res
:wordnet_antibody_115027189
is
rdf:
type
of
dbr
:Canakinumab
dbr
:Cantuzumab_mertansine
dbr
:Cantuzumab_ravtansine
dbr
:Caplacizumab
dbr
:Carlumab
dbr
:Bence_Jones_protein
dbr
:Pritumumab
dbr
:Quilizumab
dbr
:Roledumab
dbr
:Rontalizumab
dbr
:Rovelizumab
dbr
:Rozrolimupab
dbr
:Samalizumab
dbr
:Sarilumab
dbr
:Monospecific_antibody
dbr
:Polyclonal_antibodies
dbr
:Basiliximab
dbr
:Bectumomab
dbr
:Belimumab
dbr
:Benralizumab
dbr
:Bertilimumab
dbr
:Besilesomab
dbr
:Bevacizumab
dbr
:Bezlotoxumab
dbr
:Bimagrumab
dbr
:Bivatuzumab
dbr
:Bivatuzumab_mertansine
dbr
:Blinatumomab
dbr
:Blosozumab
dbr
:Brentuximab_vedotin
dbr
:Briakinumab
dbr
:Denosumab
dbr
:Detumomab
dbr
:Anti-CD19_immunotoxin
dbr
:Anti-CD3_monoclonal_antibody
dbr
:Anti-CEA_antibody
dbr
:Anti-LKM_antibody
dbr
:Anti-SSA/Ro_autoantibodies
dbr
:Anti-Scl-70_antibodies
dbr
:Anti-actin_antibodies
dbr
:Anti-apolipoprotein_antibodies
dbr
:Anti-cardiolipin_antibodies
dbr
:Anti-centromere_antibodies
dbr
:Anti-cholesterol
dbr
:Anti-dsDNA_antibodies
dbr
:Anti-gliadin_antibodies
dbr
:Anti-glomerular_basement_membrane_antibody
dbr
:Anti-glutamate_receptor_antibodies
dbr
:Anti-glycoprotein-210_antibodies
dbr
:Anti-histone_antibodies
dbr
:Anti-lymphocyte_globulin
dbr
:Anti-mitochondrial_antibody
dbr
:Anti-nRNP
dbr
:Anti-neutrophil_cytoplasmic_antibody
dbr
:Anti-p62_antibodies
dbr
:Anti-smooth_muscle_antibody
dbr
:Anti-sp100_antibodies
dbr
:Anti-streptolysin_O
dbr
:Anti-thrombin_antibodies
dbr
:Anti-topoisomerase_antibodies
dbr
:Anti-transglutaminase_antibodies
dbr
:Antibody-dependent_enhancement
dbr
:Antiganglioside_antibodies
dbr
:Anti–Saccharomyces_cerevisiae_antibody
dbr
:Anti–citrullinated_protein_antibody
dbr
:Bi-specific_T-cell_engager
dbr
:Pateclizumab
dbr
:Patritumab
dbr
:Pembrolizumab
dbr
:Pemtumomab
dbr
:Perakizumab
dbr
:Pertuzumab
dbr
:Pexelizumab
dbr
:Reslizumab
dbr
:Rho(D)_immune_globulin
dbr
:Rituximab
dbr
:Robatumumab
dbr
:Ublituximab
dbr
:Urtoxazumab
dbr
:Ustekinumab
dbr
:Vadastuximab_talirine_(SGN-CD33A)
dbr
:Vantictumab
dbr
:Vapaliximab
dbr
:Vatelizumab
dbr
:Vedolizumab
dbr
:Veltuzumab
dbr
:Vepalimomab
dbr
:Visilizumab
dbr
:Volociximab
dbr
:Vorsetuzumab_mafodotin
dbr
:Ligelizumab
dbr
:Conatumumab
dbr
:Crenezumab
dbr
:Crotalidae_polyvalent_immune_fab
dbr
:Maslimomab
dbr
:Matuzumab
dbr
:Mavrilimumab
dbr
:Ruplizumab
dbr
:Chemically_linked_Fab
dbr
:NeuN
dbr
:Trifunctional_antibody
dbr
:Single-domain_antibody
dbr
:Atinumab
dbr
:Rabbit_hybridoma
dbr
:Citatuzumab_bogatox
dbr
:Cixutumumab
dbr
:Clazakizumab
dbr
:Clenoliximab
dbr
:Efalizumab
dbr
:Efungumab
dbr
:Eldelumab
dbr
:Elotuzumab
dbr
:Elsilimomab
dbr
:Enavatuzumab
dbr
:Enoticumab
dbr
:Ensituximab
dbr
:Epratuzumab
dbr
:Fresolimumab
dbr
:Futuximab
dbr
:Galiximab
dbr
:Ganitumab
dbr
:Gantenerumab
dbr
:Gavilimomab
dbr
:Gemtuzumab_ozogamicin
dbr
:Gevokizumab
dbr
:Girentuximab
dbr
:Glembatumumab_vedotin
dbr
:Golimumab
dbr
:Minretumomab
dbr
:Mitumomab
dbr
:Mogamulizumab
dbr
:Monoclonal_antibody
dbr
:Morolimumab
dbr
:Moxetumomab_pasudotox
dbr
:Muromonab-CD3
dbr
:Nacolomab_tafenatox
dbr
:Namilumab
dbr
:Cryoglobulinemia
dbr
:SrnB-SrnC_toxin-antitoxin_system
dbr
:Anifrolumab
dbr
:Anrukinzumab
dbr
:Anti-nuclear_antibody
dbr
:Anti-thymocyte_globulin
dbr
:Antiphospholipid_syndrome
dbr
:Antivenom
dbr
:Apolizumab
dbr
:Lemalesomab
dbr
:Lerdelimumab
dbr
:Lexatumumab
dbr
:Libivirumab
dbr
:Lintuzumab
dbr
:Lirilumab
dbr
:Lorvotuzumab_mertansine
dbr
:Lucatumumab
dbr
:Lumiliximab
dbr
:Sibrotuzumab
dbr
:Sifalimumab
dbr
:Siltuximab
dbr
:Simtuzumab
dbr
:Siplizumab
dbr
:Demcizumab
dbr
:Yttrium_(90Y)_clivatuzumab_tetraxetan
dbr
:Yttrium_(90Y)_tacatuzumab_tetraxetan
dbr
:Zalutumumab
dbr
:Zanolimumab
dbr
:Zolimomab_aritox
dbr
:Fcab
dbr
:Idiotopes
dbr
:Monoclonal_antibody_therapy
dbr
:Transglutaminase
dbr
:Microantibody
dbr
:Nomenclature_of_monoclonal_antibodies
dbr
:Synthetic_antibody
dbr
:Vesencumab
dbr
:Bapineuzumab
dbr
:Brodalumab
dbr
:CR6261
dbr
:Catumaxomab
dbr
:Cedelizumab
dbr
:Certolizumab_pegol
dbr
:Cetuximab
dbr
:Tigatuzumab
dbr
:Tildrakizumab
dbr
:Tocilizumab
dbr
:Toralizumab
dbr
:Tositumomab
dbr
:Tovetumab
dbr
:Tralokinumab
dbr
:Trastuzumab
dbr
:Trastuzumab_emtansine
dbr
:Tregalizumab
dbr
:Tucotuzumab_celmoleukin
dbr
:Tuvirumab
dbr
:Heavy-chain_antibody
dbr
:Peregrine_Pharmaceuticals
dbr
:3F8
dbr
:Abagovomab
dbr
:Abciximab
dbr
:Actoxumab
dbr
:Adalimumab
dbr
:Adecatumumab
dbr
:Aducanumab
dbr
:Alacizumab_pegol
dbr
:Alemtuzumab
dbr
:Alirocumab
dbr
:Amatuximab
dbr
:Anatumomab_mafenatox
dbr
:Dacetuzumab
dbr
:Daclizumab
dbr
:Dalotuzumab
dbr
:Daratumumab
dbr
:Drozitumab
dbr
:Dupilumab
dbr
:Dusigitumab
dbr
:Ecromeximab
dbr
:Eculizumab
dbr
:Edobacomab
dbr
:Edrecolomab
dbr
:Erlizumab
dbr
:Ertumaxomab
dbr
:Etaracizumab
dbr
:Etrolizumab
dbr
:Exbivirumab
dbr
:Faralimomab
dbr
:Farletuzumab
dbr
:Fasinumab
dbr
:Felvizumab
dbr
:Fezakinumab
dbr
:Ficlatuzumab
dbr
:Figitumumab
dbr
:Flanvotumab
dbr
:Fontolizumab
dbr
:Foralumab
dbr
:Foravirumab
dbr
:Nimotuzumab
dbr
:Nivolumab
dbr
:Otelixizumab
dbr
:Otlertuzumab
dbr
:Pagibaximab
dbr
:Palivizumab
dbr
:Panitumumab
dbr
:Pankomab
dbr
:Panobacumab
dbr
:Parsatuzumab
dbr
:Pascolizumab
dbr
:Chromatin_immunoprecipitation
dbr
:FlmA-FlmB_toxin-antitoxin_system
dbr
:Fragment_antigen-binding
dbr
:Fragment_crystallizable_region
dbr
:Framework_region
dbr
:Globular_protein
dbr
:Kabat_numbering_scheme
dbr
:TxpA-RatA_toxin-antitoxin_system
dbr
:Guselkumab
dbr
:Hepatitis_B_immune_globulin
dbr
:Heterophile
dbr
:Intetumumab
dbr
:Intrabody_(protein)
dbr
:Ipilimumab
dbr
:Iratumumab
dbr
:Itolizumab
dbr
:Ixekizumab
dbr
:Talizumab
dbr
:Tanezumab
dbr
:Taplitumomab_paptox
dbr
:Technetium_(99mTc)_arcitumomab
dbr
:Technetium_(99mTc)_pintumomab
dbr
:Technetium_(99mTc)_sulesomab
dbr
:Tefibazumab
dbr
:Telimomab_aritox
dbr
:Tenatumomab
dbr
:Teneliximab
dbr
:Teplizumab
dbr
:Hyperimmune_globulin
dbr
:Hypervariable_region
dbr
:Snake_antivenom
dbr
:Aselizumab
dbr
:Atacicept
dbr
:Atorolimumab
dbr
:Abzyme
dbr
:Keliximab
dbr
:Labetuzumab
dbr
:Lampalizumab
dbr
:Lebrikizumab
dbr
:Bispecific_monoclonal_antibody
dbr
:Suvizumab
dbr
:TOL101
dbr
:Tadocizumab
dbr
:Heptavalent_botulism_antitoxin
dbr
:Duligotumab
dbr
:Zoster-immune_globulin
dbr
:Digoxin_immune_fab
dbr
:Mapatumumab
dbr
:Margetuximab
dbr
:C-ANCA
dbr
:CBR96-doxorubicin_immunoconjugate
dbr
:Pidilizumab
dbr
:Placulumab
dbr
:Solanezumab
dbr
:Solitomab
is
rdfs:
subClassOf
of
yago
:WikicatAntibodies
yago
:WikicatTherapeuticAntibodies
yago
:Agglutinin115028684
yago
:Antitoxin115028050
yago
:Autoantibody115027618
yago
:HeterophilAntibody115029292
yago
:Immunoglobulin115030481
yago
:Isoantibody115029482
yago
:MonoclonalAntibody115029781
yago
:Opsonin115030264
yago
:Precipitin115027762
yago
:WikicatPolyclonalAntibodies
This content was extracted from
Wikipedia
and is licensed under the
Creative Commons Attribution-ShareAlike 3.0 Unported License